Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Challenge Seeks New Regenerative Tools with Stem Cells

Induced pluripotent stem cells reprogrammed from human skin (California Institute for Regenerative Medicine)

29 April 2016. A challenge offered through InnoCentive is seeking new methods of harnessing adult stem cells for regenerative medicine. The competition has a total purse of $15,000 and a 24 June 2016 deadline for submissions. The sponsor of the challenge, . . . → Read More: Challenge Seeks New Regenerative Tools with Stem Cells

University Lab Spins-Off Fertility Testing Company

Katie Brenner (Bryce Richter, Univ. of Wisconsin-Madison)

29 April 2016. A new company is taking shape that aims to make it easier for women to get pregnant, based on research at a biochemistry lab at University of Wisconsin. BluDiagnostics, in Madison, founded by postdoctoral research Katie Brenner in the lab of biochemistry professor Douglas . . . → Read More: University Lab Spins-Off Fertility Testing Company

Collaboration Explores Humanitarian Satellite Applications

Microsatellite nodes in lab before launch (NASA)

28 April 2016. A start-up satellite imaging provider and agency of the United Nations are partnering on new ways to use satellite imaging to further the UN’s humanitarian, peace-keeping, and climate change mitigation missions. Financial terms between BlackSky Global LLC in Seattle and the United Nations Institute . . . → Read More: Collaboration Explores Humanitarian Satellite Applications

Engineered T-Cells Get High Leukemia Remission in Trial

Acute myeloid leukemia cells (Cancer Genome Atlas, NIH)

28 April 2016. A clinical trial shows engineered immune-system cells transplanted in patients with one form of leukemia achieves a 93 percent remission rate. Results of the trial, at the Fred Hutchinson Cancer Research Center in Seattle, were reported in the 25 April issue of The . . . → Read More: Engineered T-Cells Get High Leukemia Remission in Trial

Sanofi Adopting Big Data for Diabetes Drug Adherence

(PublicDomainPictures, Pixabay)

27 April 2016. Drug maker Sanofi is partnering with two research institutes to harness big data analytics for predicting how people with type 2 diabetes will take their medications. Sanofi’s U.S. division in Bridgewater, New Jersey announced the collaborations today with Duke Clinical Research Institute in Durham, North Carolina and Center for . . . → Read More: Sanofi Adopting Big Data for Diabetes Drug Adherence

Phones, Wearables Studied to Monitor Brain Disorders

(kaboompics.com/Pexels)

27 April 2016. A project now underway in Europe plans to develop techniques for smartphones and wearable devices to monitor people with depression, epilepsy, and multiple sclerosis. The 5-year, €22 million ($US 25 million) initiative known as Remote assessment of disease and relapse – Central Nervous System, or Radar-CNS, is funded by the . . . → Read More: Phones, Wearables Studied to Monitor Brain Disorders

NeuroVive, Penn Partner on Traumatic Brain Injury

Brain wiring illustration (Courtesy, Human Connectome Project and NIH)

26 April 2016. A pharmaceutical company in Sweden is collaborating with University of Pennsylvania’s medical school in preclinical studies of a new drug that protects against long term damage caused by traumatic brain injury. Financial terms of the agreement between NeuroVive Pharmaceutical AB in Lund, . . . → Read More: NeuroVive, Penn Partner on Traumatic Brain Injury

Genetic Techniques Quickly Build Crop Disease Resistance

Wheat stem rust (John Innes Center)

26 April 2016. Plant scientists in the U.K. developed genetic engineering techniques that quickly clone resistance to plant diseases affecting wheat, soybeans, and potatoes. The techniques are described in articles appearing in the 25 April issue of the journal Nature Biotechnology (paid subscription required).

Teams from the John . . . → Read More: Genetic Techniques Quickly Build Crop Disease Resistance

Medical Google Glass Start-Up Raises $17M in Venture Funds

Ian Shakil, Augmedix Inc. CEO, with Google Glass. (Augmedix Inc.)

25 April 2016. A company building a system that allows doctors to automatically create patient notes with Google Glass added $17 million in its second full round of venture funding. Augmedix Inc., a 2 year-old enterprise in San Francisco, says the new financing will . . . → Read More: Medical Google Glass Start-Up Raises $17M in Venture Funds

Trials to Test New Treatments for Inherited Alzheimer’s

(commonfund.nih.gov)

25 April 2016. Clinical trials are planned to assess experimental treatments and new diagnostics for inherited forms of Alzheimer’s disease. The new studies, which extend earlier trials of drugs to treat inherited Alzheimer’s disease, are funded by a $4.3 million grant from Alzheimer’s Association in Chicago.

Like the earlier trials, the new round . . . → Read More: Trials to Test New Treatments for Inherited Alzheimer’s